SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-046897
Filing Date
2024-04-23
Accepted
2024-04-23 16:10:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A rlay_-_defa_14a_2024_not.htm DEFA14A 17678
2 GRAPHIC img15132313_0.jpg GRAPHIC 1786818
3 GRAPHIC img15132313_1.jpg GRAPHIC 894846
  Complete submission text file 0000950170-24-046897.txt   3712833
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39385 | Film No.: 24864903
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)